Worldwide Non-opioid Pain Treatment Market Insights, 2018-2019 & 2024, with Comprehensive Profilings of Allergan, Canopy Growth Corp, Medical Marijuana, Panag Pharma, Tilray, and MoreHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets open in 9 hrs 16 minsS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Worldwide Non-opioid Pain Treatment Market Insights, 2018-2019 & 2024, with Comprehensive Profilings of Allergan, Canopy Growth Corp, Medical Marijuana, Panag Pharma, Tilray, and MorePR NewswireJanuary 10, 2020ReblogShareTweetShareDUBLIN, Jan. 10, 2020 /PRNewswire/ -- The "Non-opioid Pain Treatment: Global Markets to 2024" report has been added to ResearchAndMarkets.com's offering.Research and Markets LogoMoreThis report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management.The geographical scope of this study is global. This study addresses acute versus chronic pain, treatments and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts and competitive analyses.The report identifies five general product segments for Non-opioid treatment of pain:Medical cannabis treatments Capsaicin-derived treatments Menthol-containing treatments Omega 3 fatty acid-containing treatments Botulinum toxinsWithin the segment, several sub-segments are discussed as they pertain to each product segment; diseases or disorders are the basis for these sub-segments, including:Arthritis Cancer-brain, breast, colorectal, leukemia/lymphoma, melanoma, prostate, others Dental Epilepsy Fibromyalgia Migraine Multiple sclerosis SurgicalEach market segment provides detailed information based on product categories, product use, current market value and forecasts.Report ScopeAn overview of the global market for Non-opioid pain treatments Analyses of global market trends, with data from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024 Description of products included in this market, and a detailed analysis of the markets and market opportunities Information on significant products categories, issues and trends, market influences, regulatory issues and other information affecting the pain management industry Briefing about major drivers and regional dynamics of the market and current trends within the industry Comprehensive profiles of major vendors in the market, including Allergan, Canopy Growth Corp, Medical Marijuana, Panag Pharma, and TilrayKey Topics Covered Chapter 1 IntroductionStudy Goals and Objectives Reasons for Doing This Study Scope of Report Information Sources Methodology Geographic BreakdownChapter 2 Summary and HighlightsMarket Overview Drivers and RestraintsChapter 3 Market Overview and BackgroundDefinition of Pain and Nociception Pain Nociception History of Pain and Pain Treatment Types of Pain Acute Pain Chronic Pain Physiological Pain Classifications How Pain is Diagnosed How Pain is Treated Opioid vs. Non-opioid Pain Control Opioids, also Known as Narcotic Analgesics Full and Partial Agonists Agonist-Antagonists Risk and Complications in Opioid Pain Treatment Addiction and Abuse Challenges of Breakthrough Pain Control Alternative Methods of Pain Management Alternative Non-opioid Therapies for Treating Pain Medical Cannabis Capsaicin-derived Compound Menthol-containing Compound Omega 3 Fatty Acid-containing Supplements Botulinum Toxins (OnabotulinumtoxinA/RimabotulinumtoxinB) Others Growing Trend in Cannabis Treatment for Pain Adoption of Medical Cannabis: A Global Analysis Laws and Legalization Trends Claims in Effectiveness Potency and Validation Testing Trends Hospice Care Access to Palliative Care Around the World Assessing the Need for Palliative Care Market Influences and Indicators of Growth Demographic Overview Incidence and Prevalence of Conditions with Pain SymptomsChapter 4 Market Breakdown by Product SegmentOverview Medical Cannabis Capsaicin-derived Therapies Menthol-containing Therapies Omega-3 Fatty Acid-containing Therapies Botulinum Toxin TreatmentsChapter 5 Market Breakdown by Therapeutic ApplicationOverview Alternative Non-opioid Cancer Pain Treatment Alternative Non-opioid Neuropathic Pain Treatment Alternative Non-opioid Orthopedic/Musculoskeletal Pain Treatments Other Alternative Non-Opioid Pain TreatmentsChapter 6 Market Breakdown by RegionOverview Regional Groupings North America North America: Pioneer in the Medicinal Cannabis Industry Canada United States EMEA France Germany Italy Russia Spain United Kingdom Asia-Pacific Australia/New Zealand China Japan Latin America Argentina Brazil MexicoChapter 7 Patent AnalysisPatent Analysis Overview Non-opioid Pain Relief Categories Medical Cannabis Technologies Cannabis Patent Review by Year Patent Review by Company Patent Review by AssigneeChapter 8 Company ProfilesAllergan PLC Aphria Inc. Aurora Bedrocan Canopy Growth Corp. Cara Therapeutics Centrexion Therapeutics CHT Medical Cronos Group GW Pharmaceuticals Medical Marijuana Inc. Medropharm GmbH Panag Pharma Inc. Tilray US Worldmeds LLC VanwayFor more information about this report visit https://www.researchandmarkets.com/r/j5g0unResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.Media Contact:Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716CisionMoreView original content:http://www.prnewswire.com/news-releases/worldwide-non-opioid-pain-treatment-market-insights-2018-2019--2024-with-comprehensive-profilings-of-allergan-canopy-growth-corp-medical-marijuana-panag-pharma-tilray-and-more-300984846.htmlSOURCE Research and MarketsReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextAsian markets continue to slump, as Nikkei enters correction territoryMarketWatchOil’s Worst Week Since 2011 Puts Pressure on OPEC+ to RespondBloombergSiteOne Landscape Supply adds Lowe's veteran to its C-SuiteAmerican City Business JournalsItalian PM Conte says EU should look at competition rules to build European championsReutersNorway's sovereign wealth fund gains £140bn in one year - £26,400 for every citizenThe IndependentBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoCrocs CEO explains its major turnaroundYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoKorea Cases Top 2,000; Nigeria Confirms Infection: Virus UpdateBloombergWhat the GM strike means for the U.S. economyYahoo FinanceWhy negative interest rates are 'seriously dangerous': strategistYahoo FinanceAurora Cannabis tumbles after double downgradeYahoo Finance VideoCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance Video